Cargando…

Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer

OBJECTIVE: To evaluate the computed tomography (CT) features for diagnosing metastatic cervical lymph nodes (LNs) in patients with differentiated thyroid cancer (DTC) and validate the CT-based risk stratification system suggested by the Korean Thyroid Imaging Reporting and Data System (K-TIRADS) gui...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Yun Hwa, Chung, Sae Rom, Baek, Jung Hwan, Choi, Young Jun, Sung, Tae-Yon, Song, Dong Eun, Kim, Tae Yong, Lee, Jeong Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550739/
https://www.ncbi.nlm.nih.gov/pubmed/37793671
http://dx.doi.org/10.3348/kjr.2023.0308
_version_ 1785115614273077248
author Roh, Yun Hwa
Chung, Sae Rom
Baek, Jung Hwan
Choi, Young Jun
Sung, Tae-Yon
Song, Dong Eun
Kim, Tae Yong
Lee, Jeong Hyun
author_facet Roh, Yun Hwa
Chung, Sae Rom
Baek, Jung Hwan
Choi, Young Jun
Sung, Tae-Yon
Song, Dong Eun
Kim, Tae Yong
Lee, Jeong Hyun
author_sort Roh, Yun Hwa
collection PubMed
description OBJECTIVE: To evaluate the computed tomography (CT) features for diagnosing metastatic cervical lymph nodes (LNs) in patients with differentiated thyroid cancer (DTC) and validate the CT-based risk stratification system suggested by the Korean Thyroid Imaging Reporting and Data System (K-TIRADS) guidelines. MATERIALS AND METHODS: A total of 463 LNs from 399 patients with DTC who underwent preoperative CT staging and ultrasound-guided fine-needle aspiration were included. The following CT features for each LN were evaluated: absence of hilum, cystic changes, calcification, strong enhancement, and heterogeneous enhancement. Multivariable logistic regression analysis was performed to identify independent CT features associated with metastatic LNs, and their diagnostic performances were evaluated. LNs were classified into probably benign, indeterminate, and suspicious categories according to the K-TIRADS and the modified LN classification proposed in our study. The diagnostic performance of both classification systems was compared using the exact McNemar and Kosinski tests. RESULTS: The absence of hilum (odds ratio [OR], 4.859; 95% confidence interval [CI], 1.593–14.823; P = 0.005), strong enhancement (OR, 28.755; 95% CI, 12.719–65.007; P < 0.001), and cystic changes (OR, 46.157; 95% CI, 5.07–420.234; P = 0.001) were independently associated with metastatic LNs. All LNs showing calcification were diagnosed as metastases. Heterogeneous enhancement did not show a significant independent association with metastatic LNs. Strong enhancement, calcification, and cystic changes showed moderate to high specificity (70.1%–100%) and positive predictive value (PPV) (91.8%–100%). The absence of the hilum showed high sensitivity (97.8%) but low specificity (34.0%). The modified LN classification, which excluded heterogeneous enhancement from the K-TIRADS, demonstrated higher specificity (70.1% vs. 62.9%, P = 0.016) and PPV (92.5% vs. 90.9%, P = 0.011) than the K-TIRADS. CONCLUSION: Excluding heterogeneous enhancement as a suspicious feature resulted in a higher specificity and PPV for diagnosing metastatic LNs than the K-TIRADS. Our research results may provide a basis for revising the LN classification in future guidelines.
format Online
Article
Text
id pubmed-10550739
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-105507392023-10-06 Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer Roh, Yun Hwa Chung, Sae Rom Baek, Jung Hwan Choi, Young Jun Sung, Tae-Yon Song, Dong Eun Kim, Tae Yong Lee, Jeong Hyun Korean J Radiol Thyroid OBJECTIVE: To evaluate the computed tomography (CT) features for diagnosing metastatic cervical lymph nodes (LNs) in patients with differentiated thyroid cancer (DTC) and validate the CT-based risk stratification system suggested by the Korean Thyroid Imaging Reporting and Data System (K-TIRADS) guidelines. MATERIALS AND METHODS: A total of 463 LNs from 399 patients with DTC who underwent preoperative CT staging and ultrasound-guided fine-needle aspiration were included. The following CT features for each LN were evaluated: absence of hilum, cystic changes, calcification, strong enhancement, and heterogeneous enhancement. Multivariable logistic regression analysis was performed to identify independent CT features associated with metastatic LNs, and their diagnostic performances were evaluated. LNs were classified into probably benign, indeterminate, and suspicious categories according to the K-TIRADS and the modified LN classification proposed in our study. The diagnostic performance of both classification systems was compared using the exact McNemar and Kosinski tests. RESULTS: The absence of hilum (odds ratio [OR], 4.859; 95% confidence interval [CI], 1.593–14.823; P = 0.005), strong enhancement (OR, 28.755; 95% CI, 12.719–65.007; P < 0.001), and cystic changes (OR, 46.157; 95% CI, 5.07–420.234; P = 0.001) were independently associated with metastatic LNs. All LNs showing calcification were diagnosed as metastases. Heterogeneous enhancement did not show a significant independent association with metastatic LNs. Strong enhancement, calcification, and cystic changes showed moderate to high specificity (70.1%–100%) and positive predictive value (PPV) (91.8%–100%). The absence of the hilum showed high sensitivity (97.8%) but low specificity (34.0%). The modified LN classification, which excluded heterogeneous enhancement from the K-TIRADS, demonstrated higher specificity (70.1% vs. 62.9%, P = 0.016) and PPV (92.5% vs. 90.9%, P = 0.011) than the K-TIRADS. CONCLUSION: Excluding heterogeneous enhancement as a suspicious feature resulted in a higher specificity and PPV for diagnosing metastatic LNs than the K-TIRADS. Our research results may provide a basis for revising the LN classification in future guidelines. The Korean Society of Radiology 2023-10 2023-09-22 /pmc/articles/PMC10550739/ /pubmed/37793671 http://dx.doi.org/10.3348/kjr.2023.0308 Text en Copyright © 2023 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Thyroid
Roh, Yun Hwa
Chung, Sae Rom
Baek, Jung Hwan
Choi, Young Jun
Sung, Tae-Yon
Song, Dong Eun
Kim, Tae Yong
Lee, Jeong Hyun
Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer
title Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer
title_full Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer
title_fullStr Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer
title_full_unstemmed Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer
title_short Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer
title_sort validation of ct-based risk stratification system for lymph node metastasis in patients with thyroid cancer
topic Thyroid
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550739/
https://www.ncbi.nlm.nih.gov/pubmed/37793671
http://dx.doi.org/10.3348/kjr.2023.0308
work_keys_str_mv AT rohyunhwa validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer
AT chungsaerom validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer
AT baekjunghwan validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer
AT choiyoungjun validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer
AT sungtaeyon validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer
AT songdongeun validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer
AT kimtaeyong validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer
AT leejeonghyun validationofctbasedriskstratificationsystemforlymphnodemetastasisinpatientswiththyroidcancer